Rejoinder to comments on ‘‘Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China’’ - Floriano Amimo (Human Vaccines & Immunotherapeutics)